Thomas J. Schall - Jan 1, 2022 Form 4 Insider Report for ChemoCentryx, Inc. (CCXI)

Role
President and CEO, Director
Signature
/s/ Susan M. Kanaya, as Attorney-in-Fact
Stock symbol
CCXI
Transactions as of
Jan 1, 2022
Transactions value $
-$1,663,864
Form type
4
Date filed
1/4/2022, 08:42 PM
Previous filing
Dec 3, 2021
Next filing
Feb 25, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CCXI Common Stock Options Exercise $0 +23.3K +0.99% $0.00 2.38M Jan 1, 2022 Direct F1
transaction CCXI Common Stock Options Exercise $0 +34.6K +1.45% $0.00 2.41M Jan 1, 2022 Direct F2
transaction CCXI Common Stock Options Exercise $0 +26.3K +1.09% $0.00 2.44M Jan 1, 2022 Direct F3
transaction CCXI Common Stock Tax liability -$1.66M -45.7K -1.87% $36.41 2.39M Jan 1, 2022 Direct F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CCXI Restricted Stock Units Options Exercise -23.3K -100% 0 Jan 1, 2022 Common Stock 23.3K Direct F5, F6
transaction CCXI Restricted Stock Units Options Exercise -34.6K -50% 34.6K Jan 1, 2022 Common Stock 34.6K Direct F5, F7
transaction CCXI Restricted Stock Units Options Exercise -26.3K -33.33% 52.7K Jan 1, 2022 Common Stock 26.3K Direct F5, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were acquired upon vesting of restricted stock units awarded on March 4, 2019.
F2 Shares were acquired upon vesting of restricted stock units awarded on March 3, 2020.
F3 Shares were acquired upon vesting of restricted stock units awarded on February 25, 2021.
F4 Represents shares withheld upon vesting of restricted stock units to satisfy tax withholding obligation.
F5 Each restricted stock unit represents a contingent right to receive one share of CCXI common stock.
F6 The restricted stock units awarded on March 4, 2019, vest in three equal installments on January 1, 2020, January 1, 2021, and January 1, 2022, subject to the Reporting Person's continued service to the Company on such date. Shares will be delivered to the Reporting Person within thirty (30) days following vest date.
F7 The restricted stock units awarded on March 3, 2020, vest in three equal installments on January 1, 2021, January 1, 2022, and January 1, 2023, subject to the Reporting Person's continued service to the Company on such date. Shares will be delivered to the Reporting Person within thirty (30) days following vest date.
F8 The restricted stock units awarded on February 25, 2021, vests in three equal installments on January 1, 2022, January 1, 2023, and January 1, 2024, subject to the Reporting Person's continued service to the Company on such date. Shares will be delivered to the Reporting Person within thirty (30) days following vest date.